Every FMS/CFS patient should know both their NKC number and activity.

[Guest guest]

January 30, 2004

Every FMS/CFS patient should know both their NKC number and activity.

I have found that over half of chronic fatigue and fibromyalgia

patients have low natural killer cell numbers or activity. The

function of the natural killer cells (NKC) is to kill viruses,

intracellular bacteria and cancer. They roam throughout the body in

search of infected or cancerous cells to destroy. If the natural

killer cells are low in number (NKC number) or poorly functioning

(NKC activity), there is a diminished ability to kill cancer cells in

the body, resulting in an increased risk for all types of cancer.

Every fibromyalgia and chronic fatigue patient should know both their

NKC number and activity. There are a number of specific treatments

that can be done to dramatically improve natural killer cell number

and activity, with resultant increased ability to rid the body of the

infectious components and to reverse the increased risk for cancer.

~Kent Holtorf MD, Fibromyalgia and Fatigue Centers, Inc. Widespread

body pain and mortality: prospective population based study.

Macfarlane GJ, McBeth J, Silman AJ. Unit of Chronic Disease

Epidemiology, Medical School, University of Manchester, Manchester

M13 9PT. G.Macfarlane@... OBJECTIVE: To determine whether there

is excess mortality in groups of people who report widespread body

pain, and if so to establish the nature and extent of any excess.

DESIGN: Prospective follow up study over eight years. Mortality rate

ratios were adjusted for age group, sex, and study location. SETTING:

Northwest England. PARTICIPANTS: 6569 people who took part in two

pain surveys during 1991-2. MAIN OUTCOME MEASURES: Pain status at

baseline and subsequent mortality. RESULTS: 1005 (15%) participants

had widespread pain, 3176 (48%) had regional pain, and 2388 (36%) had

no pain. During follow up mortality was higher in people with

regional pain (mortality rate ratio 1.21, 95% confidence interval

1.01 to 1.44) and widespread pain (1.31, 1.05 to 1.65) than in those

who reported no pain. The excess mortality among people with regional

and widespread pain was almost entirely related to deaths from cancer

(1.55 (1.09 to 2.19) for regional pain and 2.07 (1.37 to 3.13) for

widespread pain). The excess cancer mortality remained after

exclusion of people in whom cancer had been diagnosed before the

original survey and after adjustment for potential

confoundingfactors. There were also more deaths from causes other

than disease (for example, accidents, suicide, violence) among people

with widespread pain (5.21, 0.94 to 28.78). CONCLUSION: There is an

intriguing association between the report of widespread pain and

subsequent death from cancer in the medium and long term. This may

have implications for the long term follow up of patients

with " unexplained " widespread pain symptoms, such as those with

fibromyalgia.